Home | Sitemap
 
 
 
Call us at
Toll Free (866) 317-1348
               (714) 783-7827
               (808) 689-1710
 
   
 
 
*
as submitted to the Compendium 
Roulet D.N., Steiner D.M., Kallet M.P., Steiner G.G.

INTRODUCTION

Periodontal therapy has made significant strides in developing methods and materials for regenerating lost tissue. The most common method of regenerating lost periodontal tissue is guided tissue regeneration. The success of this method is dependant on the exclusion of cells from the periodontal defect.  A superior approach to the exclusion of cells may be the placement of cells in the periodontal defect with the potential to produce cementum, periodontal ligament and bone. Bone repair in the skeleton occurs readily with regeneration of ligament and muscle reattachment. This method of healing found in the skeleton can be applied to the diseased periodontium.    

Tissue regeneration of any type has certain requirements to be successful. Initially, a space is necessary for regeneration to take place. In addition, the correct cells with the potential to create the desired tissue must to be present in the regenerative site. The raw materials needed to produce the tissue must be available and the cells with the potential to produce the tissue must be stimulated. Lastly, the correct physiologic environment must be present to optimize the regenerative potential. Given these factors, the body possesses the inherent genetic potential to recreate lost tissue.

Regenerative surgery using inert membranes and granular bone graft materials requires resorption of the graft materials before regeneration can occur. Cells capable of resorbing the graft material must be brought to the site and resorb the graft material prior to the initiation of regeneration. Significant loss of graft volume occurs as a result of resorption or rejection of the graft material. In addition, inert membranes used in the traditional manner have no benefit for use in horizontal bone loss. According to the American Academy of Periodontology’s position paper on regenerative therapy, inert membranes have little benefit in class three furcations but show some improvement when used to treat class two furcations. Although barrier membranes show an improvement in connective tissue attachment and bone when treating class two furcations, they cannot completely regenerate these furcation defects. Inert barrier membranes have been shown to be most effective when used to treat three wall bony defects.1 

The inverted periosteal graft delivers cells to the periodontal lesion that have the potential to regenerate cementum, periodontal ligament and bone. The maxilla and mandible are formed by intramembranous bone formation. Embryonic mesenchyme cells arrange in sheets in the facial tissue and produce the facial bones. After the facial bones are formed the sheet of mesenchyme cells turns into the periosteum. The cells of the periosteum retain much of their pluripotent properties.

Adult human periosteum is known to possess fibroblasts and osteoblasts as well as their progenitor cells. However, adult human periosteum has also been found to contain a significant number of multipotent mesenchymal stem cells. Regardless of age, periosteal cells have been found to be clonogenic, display long telomeres and express markers of mesenchymal stem cells. Both parental and single-cell-derived clonal cell populations derived from adult periosteum have been found to differentiate to the chondrocyte, osteoblast, adipocyte, and skeletal myocyte lineages in vitro and in vivo. The adult human periosteum contains cells that are multipotent mesenchymal stem cells at the single-cell level.2

The inverted periosteal graft populates the defect with fibroblasts that have the ability to produce cementum and periodontal ligament and osteoblasts, which can produce bone. The outer layer of the periosteum, which is adjacent to soft connective tissue, is comprised of fibroblasts and their progenitor cells. Research shows that these cells can produce cementum with integrated collagen fibers when placed over dentin.3 In the inverted periosteal graft, cells on the outer layer of the periosteum (those with the ability to produce cementum and periodontal ligament) are inverted, and cover the coronal portion of the periodontal defect. In this manner, the first cells to populate the periodontal defect are cells of the outer periosteal layer which have been shown to posses the ability to produce cementum and periodontal ligament.

The most critical phase of regenerative periodontal therapy is reattachment of collagen fibers to the root surface. However, regeneration of lost bone needs to follow reattachment of collagen to the root surface. The normal anatomy of the periosteum includes an outer layer of fibroblasts adjacent to the soft connective tissue and an inner layer of osteoblasts and their progenitor cells adjacent to bone. The periosteum is very thin, and its inner and outer layers are in intimate contact with each other. By design, the inversion of the periosteum places fibroblasts and their progenitor cells immediately over the periodontal defect in order to populate the defect with fibroblasts and their progenitor cells. However, osteoblasts and their progenitor cells cover the layer of fibroblasts and follow them into the defect. During healing, the cells with the potential to regenerate cementum and periodontal ligament are the first cells to populate the root surface and the osseous defect. Osteoblasts and their progenitor cells are immediately behind the fibroblasts and populate the osseous defect. The inverted periosteal graft places the proper cells in the proper location so that the correct sequence of regeneration can occur.

Training in the use of inert barriers has instilled in our surgical technique the need to suture the barrier tightly against the root surface. Any area without firm barrier-to-tooth apposition is likely to have invasion of gingival cells resulting surgical failure. When using the inverted periosteal graft, firm apposition of the periosteum to the root surface is not required. The inverted periosteal graft is not guided tissue regeneration. While close apposition of the periosteum to the root surface may be good surgical technique, merely placing cells with the potential to regenerate lost tissue in the area of the defect is adequate for success. There is no need to block the invasion of epithelial cells. With the root surface populated with fibroblasts and collagen, epithelial invasion would be contrary to normal wound healing. When the body has the proper cells available to regenerate itself, it is programmed to produce normal tissue.

The periosteum covers the majority of the bones in the body. If the periosteum is grafted into soft connective tissue it will grow bone in areas where bone is not found. The periosteum is a very dense, tough layer of fibrous tissue intended to act as a covering for bone and provide progenitor cells for bone growth and repair. In the mouth, the periosteum can be found in most areas where bone is covered with mucosa but not in areas of attached gingiva. The hard palate is covered with periosteum as it is covered with keratinized gingiva but not attached gingiva.  Bone covered by periosteum is always cortical bone.  

 In the mouth, the periosteum begins at the mucogingival junction and covers the majority of the maxilla and mandible. As a result, an entire arch or entire mouth can be treated at one appointment due to the availability of periosteum adjacent to the graft site. The inverted periosteal graft reduces the cost of surgery by eliminating the need for barrier membranes. Additionally, the inverted periosteal graft eliminates many of the side effects of barrier surgery such as allergic reactions, infection, rejection and the need to remove a foreign object.

The anatomic location of the periosteum is a significant factor in the reconstruction of lost periodontium. Attached gingiva has no ability to produce cementum, periodontal ligament, or bone. In fact, attached gingiva likely plays a roll in blocking bone growth and facilitating reepithelization of the periodontal lesion. Guided tissue regeneration, using inert membranes, is widely believed to be successful because it blocks the epithelium from growing down the root surface and reforming the periodontal pocket. However, the possibility also exists that guided tissue regeneration is successful because it excludes attached gingiva which may inhibit the regeneration of bone and periodontal ligament. Irrespective of why guided tissue regeneration works, it is accepted as a predictable way to regenerate lost periodontium. However, it is also accepted that guided tissue regeneration is limited and useful only in certain types of periodontal lesions. 

The inverted periosteal graft retains its attachment to either the gingival flap or alveolar bone. The periosteum thereby retains its blood supply and will survive even if exposed after surgery. Because the inverted periosteal graft is attached to either the gingival flap or the bone it can be sutured securely over the graft site to hold the bone graft material and maintain space for regeneration.  

The inverted periosteal graft can be used with any graft material. However, a there exists a wide disparity of results between the various commercially available bone graft materials. The majority of bone graft materials are osteoconductive. This term describes a graft material that is porous and has the ability to allow ingrowth of cells into the graft site. Most osteoconductive materials are considered to be resorbable; however, the rate of resorption is based largely upon the patient’s physiology. Hard granular graft material often significantly inhibits the regeneration of bone due to the difficulty and time needed to remove the graft material from the graft site. The only cells capable of removing hard granular graft material are osteoclasts. Hard graft material requires the graft site be populated with cells that remove bone rather than cells that regenerate bone.

The ideal graft material should not require removal prior to the initiation of regeneration; it should stimulate osteoblasts and inhibit osteoclasts to prevent collapse of the graft site. The graft material should supply the raw materials used in bone formation and be simply and efficiently converted by osteoblasts into bone. Another significant factor in regenerating bone is that, by themselves, local osteoblasts in alveolar bone have limited regenerative potential.

The inverted periosteal graft, in combination with the proper graft material, stimulates regenerative cells, inhibits resorptive cells and supplies the raw material for regeneration. The inverted periosteal graft is designed to place progenitor cells that have the potential to regenerate cementum, periodontal ligament and bone, in the proper position to immediately begin the regenerative process when surgery is complete.

DESCRIPTION AND ILLUSTRATION

The inverted periosteal graft is intended to acquire the periosteum and place it in the vicinity of the periodontal lesion. There are two different methods that can be utilized to achieve the same result. It is up to the operator to determine which technique is appropriate. One method is to raise a split thickness flap leaving the periostium covering the bone. The flap is extended apically to a point where the periostium can be incised and lifted off the bone. With this method, the periosteum remains attached to the bone near the mucogingival junction. Once the periodontal lesions are treated and grafted, the buccal and lingual periosteal membranes are sutured interproximally with resorbable sutures. After suturing the periosteum over the bone grafts, the buccal and lingual gingival flaps are closed over the inverted periosteum.

Another method is to raise a full thickness flap, incise the periosteum at the apical extent of the flap, and dissect the periostium off the flap until the mucogingival junction is reached. Again, after the lesions are treated and bone grafts are placed the periosteal flaps are sutured interproximally. After the inverted periosteal flaps are closed over the bone grafts, the buccal and lingual gingival flaps are sutured.

The decision regarding whether to use a split thickness or full thickness flap approach will depend on may factors such as the nature of the lesion, the amount of attached gingiva, the location of the periostium, the position of the teeth and the operator’s skill. Every patient presents with a unique set of circumstances, and as a result, the inverted periosteal graft requires considerable forethought prior to initiating the surgery. Due to the unique characteristics of this surgery it is advised that training in this surgical technique be acquired if the best possible result is to be achieved.

The following case walks through the significant aspects of the inverted periosteal graft. This patient presented with adult periodontitis. Significant horizontal bone loss with vertical defects were present upon examination. Approximately 2 mm exposed cementum was found as a result of gingival recession. The periodontal tissue was cyanotic and bled when probed.

 
Figure 1   Seven to eight mm probings are found mesial to #12 and distal to #13 and #14. Recession, vasodilatation and cyanosis are evident.

Figure 1


Figure 2 The lingual preoperative view.

Figure 2


Figure 3 Preoperative radiograph showing vertical defects mesial #12, distal #13 and #14.

Figure 3


Figure 4  Buccal view of horizontal bone loss.

Figure 4


Figure 5 Granulation tissue removed showing vertical defects mesial #12, distal #13 and 14.

Figure 5


Figure 6 Palatal alveolar bone loss.

Figure 6


Figure 7 The periosteum is incised at the base of the flap and dissected off the buccal flap. The periosteum is rolled up at the mucogingival junction and grasped with the pickups buccal to the bicuspids.

Figure 7


Figure 8 The periosteum is incised at the base of the palatal flap and dissected coronally. In this photo the periosteum is grasped by the tissue pickups.

Figure 8


Figure 9 The buccal periosteum is sutured to the lingual periosteum. The periosteum is reflected back between the bicuspids to show the underlying bone graft.

Figure 9


Figure 10 The lingual periosteum is sutured to the buccal periosteum.

Figure 10


Figure 11  One month post operative radiograph showing reossification of the periodontal lesions.

Figure 11


Figure 12 At one month post op the gingival margins are maintained with loss of some interproximal tissue. The vascular dilation and cyanosis is resolved. The interproximal tissue will regenerate to some degree. At one month after surgery probing between 11 and 12 is zero. These areas will regenerate a normal architecture as healing progresses. In the rest of the quadrant the probings are 2 and 3 millimeters.  

Figure 12


Figure 13 At one month post op. The gingival margin is maintained at pre op levels with loss of interproximal tissue around the bicuspids. Tissue health is excellent with no probing defects or bleeding upon probing.

Figure 13


Figure 14  Preoperative radiograph showing a moderate mesial angular lesion on #19 with a severe interproximal lesion to near apex between #18 and 19 including furcation involvement on #18 and distal bone loss #18.

Figure 14


Figure 15  One month after surgery using an inverted periosteal graft and grafting with REGEN BIOCEMENT wetted with HYDRASE graft wetting agent probings are within normal limits and radiodensity of the bone is increasing.

Figure 15


Figure 16  Three months after surgery the mesial lesion on #19 has resolved. The interproximal lesion between #18 and 19 has resolved with increasing bone density. The furcation on #18 has filled with bone

Figure 16


Figure 17 At seven months post op bone density in the previous lesions is becoming indistinguishable from the surrounding bone. The gingival tissues are healthy with no probing defects.

Figure 17


Figure 18  This preoperative radiograph shows a class two mesial furcation on #14.

Figure 18


Figure 19  The post op radiograph shows new bone formation in the mesial defect with no probing defects. The regenerated bone shows greater density than the surrounding bone.

Figure 19


Figure 20 Tooth #14 exhibits  severe class three furcation bone loss with endodontic disease. Clinically the gingiva on distal buccal root exhibited recession to the apex.

Figure 20


Figure 21 After DB root amputation and an inverted periosteal graft with REGEN BIOCEMENT wetted with HYDRASE graft wetting agent  80% of the furcation bone is regenerated. Again, the regenerated bone shows greater density that the surrounding bone.

Figure 21


Figure 22  Buccal view of the previous case 6 months post op showing excellent health with no probing defects. Endodontics and restorative dentistry courtesy of Dr. Ron Ask.

Figure 22


Figure 23 Lingual view of the previous case 6 months post op shows excellent health with no probing defects. Endodontics and restorative dentistry courtesy of Dr. Ron Ask.

Figure 23


Figure 24 Preoperative radiograph of tooth #31 with 7mm mesial probing and 12 mm distal probing with a one wall lingual moat from mesial to distal.

Figure 24


Figure 25 One month post op radiograph after inverted periosteal graft with REGEN BIOCEMENT wetted with HYDRASE graft wetting agent. Reossification of lesions are occurring with all probings within normal limits.

Figure 25


Figure 26  One month post op photograph of the previous case. No bleeding upon probing and all probings within normal limits.

Figure 26


Figure 27 is a 7 month radiograph of the previous case

Figure 27


Figures 28, 29, 30 and 31 are preoperative information on an example of a challenging case. The patient was an insulin dependant diabetic and dental phobic.  

Figure 28

Figure 29

Figure 30



Figure 31


This patient treated with full mouth inverted periosteal grafts using REGEN BIOCMENT wetted with HYDRASE graft wetting agent at one visit under general anesthesia. The patient responded well to therapy even though she stopped taking her insulin and her oral hygiene was mediocre. Figures 32,33,34 and 35 show her post operative results. Due to her intense dental phobia discussion of sinus grafting and implant placement was postponed until the patient completed periodontal therapy.

Figure 32

Figure 33

Figure 34



Figure 35

DISCUSSION

The dimension and thickness of the periosteum varies in different areas of the mouth and between patients. Vital structures underneath the periosteum must be understood and considered during surgery. However, accessing the periosteum and acquiring the graft can be accomplished quickly and effectively with the proper training and experience. This surgical modality allows the practitioner to efficiently and effectively perform regenerative surgery on all surfaces for all teeth in a quadrant or mouth in less time than is required to place isolated barrier membranes.

Bone regeneration of periodontal lesions is unique because most bones are covered by periosteum and no other part of the body has attached gingiva. The inverted periosteal graft heals periodontal lesions by utilizing the same healing process seen in the regeneration of bone fractures, where periosteum is a primary ingredient. By using the body’s own healing mechanism for bone regeneration the inverted periosteal graft may prove to be advancement in the regeneration of bone lost due to periodontal disease.

Although this presentation is unable to outline all of the necessary information to integrate this surgical modality into a periodontal practice, it provides a brief overview of the procedure and its potential benefits. In the experience of the authors the integration of the inverted periosteal graft has lead to the ability to treat more advanced cases successfully. As in all treatment modalities, experience has led to the refinement of this technique and a better understanding of what is needed to achieve regenerative success. In order to predictably achieve regenerative success it is advised that additional training in the use of the inverted periosteal graft be acquired before attempting this surgery.

The graft material used for these procedures was REGEN BIOCEMENT wetted with HYDRASE graft wetting agent. REGEN BIOCEMENT is a dual phase calcium phosphate based cement that promotes osteoconduction. In addition, REGEN BIOCEMENT also contains synthetic biologically active compounds that stimulate osteoblasts and inhibit osteoclasts and phagocytes. REGEN BIOCEMENT is non ceramic and does not require osteoclasts for resorption.

HYDRASE graft wetting agent is specifically designed as a bone graft wetting agent. HYDRASE provides an ideal physiologic environment for osteogenesis. When REGEN BIOCEMENT is wetted with HYDRASE graft wetting agent, the graft material stimulates osteoblasts, inhibits osteoclasts and phagocytosis and provides the proper compounds required by osteoblasts to form bone in an ideal physiologic environment. Bone formed with REGEN BIOCEMENT wetted with HYDRASE graft wetting agent is most commonly cortical bone. Following is a typical histological section of a site grafted with REGEN BIOCEMENT wetted with HYDRASE graft wetting agent.

Figure 36 REGEN BIOCEMENT wetted with HYDRASE 18 weeks post op. cortical bone with Haversion canal. Magnification 100 power

Figure 36


Figure 37 REGEN BIOCEMENT wetted with HYDRASE 18 weeks post op. cortical bone with Haversion canal. Magnification 400 power

Figure 37

 
* The inverted periosteal graft is the intellectual property of STEINER LABORATORIES. STEINER LABORATORIES permits use of this surgical modality free of charge with written permission from STEINER LABORATORIES.

1. American Academy of Periodontology position paper on regenerative therapy, May 2005.

2. De Bari C, Dell'Accio F, Vanlauwe J, Eyckmans J, Khan I, Archer C, Jones E, McGonagle D, Mitsiadis T, Pitzalis C, Luyten F. Mesenchymal Multipotency of Adult Human Periosteal Cells Demonstrated by Single-Cell Lineage Analysis. Arthritis & Rheumatism, April 2006, 54:4, pp. 1209-1221.

3. Groeneveld MC, Everts V, Beertsen W. Formation of afibrillar acellular cementum-like layers induced by alkaline phosphatase activity from periodontal ligament explants maintained in vitro. J Dent Res 1994;73:1588-1592.
 
     
 
Home - Bone Graft Products - The Bone Institute™ - Bone Central - Neutraceuticals - Publications - Ordering - Sitemap
 
Call us toll free (866) 317-1348
(714) 783-7827
(808) 689-1710
If you have any questions, please contact us at .
Please visit our terms of use agreement and privacy policy for information governing the use of this site.
© STEINER LABORATORIES All rights reserved